Sign In
Buy RXRX
$3.52
+0.180 (+5.39%)
At Close: Jun 26, 2026
Down -26.36% in 4 Weeks, Here's Why Recursion Pharmaceuticals (RXRX) Looks Ripe for a Turnaround
10:36am, Wednesday, 03'rd Apr 2024
Recursion Pharmaceuticals (RXRX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising ea
All You Need to Know About Recursion Pharmaceuticals (RXRX) Rating Upgrade to Buy
01:00pm, Monday, 01'st Apr 2024
Recursion Pharmaceuticals (RXRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Not just Soundhound, these AI stocks are also riding Nvidia wave
06:34am, Saturday, 16'th Mar 2024
Following Nvidia's investment disclosure, SoundHound AI's shares have dramatically increased, tripling in value and boosting its market capitalization to $2.75 billion. The company's success is attrib
Recursion Pharmaceuticals Stock Has 33% Upside, According to 1 Wall Street Analyst
10:28am, Thursday, 07'th Mar 2024
The company just took full control of one of its collaborations with Bayer. It'll take a long time for this play to demonstrate any value.
Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too?
02:00pm, Friday, 01'st Mar 2024
The U.S. spends approximately $450 billion every year treating rare diseases. Investing guru Cathie Wood says managing patients afflicted with these illnesses could cost $20 trillion over their lifeti
Recursion to Participate in Upcoming Investor Conferences
07:59am, Friday, 01'st Mar 2024
SALT LAKE CITY, March 01, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its participatio
Recursion Pharmaceuticals, Inc. (RXRX) Q4 2023 Earnings Call Transcript
11:27pm, Tuesday, 27'th Feb 2024
Recursion Pharmaceuticals, Inc. (RXRX) Q4 2023 Earnings Call Transcript
Recursion Pharmaceuticals (RXRX) Reports Q4 Loss, Lags Revenue Estimates
07:36pm, Tuesday, 27'th Feb 2024
Recursion Pharmaceuticals (RXRX) came out with a quarterly loss of $0.40 per share versus the Zacks Consensus Estimate of a loss of $0.46. This compares to loss of $0.31 per share a year ago.
Insiders spill: The next big tech stock set to explode in value
10:06am, Tuesday, 20'th Feb 2024
2023 proved to be a rather fruitful year for tech investors, with NASDAQ finishing 43% up compared to the disappointment that was 2022.
Analysts Estimate Recursion Pharmaceuticals (RXRX) to Report a Decline in Earnings: What to Look Out for
11:05am, Monday, 19'th Feb 2024
Recursion Pharmaceuticals (RXRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Recursion Pharmaceuticals (RXRX) Surges 13.8%: Is This an Indication of Further Gains?
03:56am, Friday, 16'th Feb 2024
Recursion Pharmaceuticals (RXRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further str
Why Recursion Pharmaceuticals Stock Zoomed Higher on Thursday
06:27pm, Thursday, 15'th Feb 2024
A new(ish) investor has plowed $76 million into the biotech company. Recursion has been developing artificial intelligence models for drug discovery.
13F Season: 3 Whales to Follow
06:21pm, Thursday, 15'th Feb 2024
Tracking 13F filings is crucial for market participants seeking to understand trends, identify potential investment opportunities, and monitor the transactions of Wall Street's most influential invest
Nvidia discloses investments in smaller AI firms
05:22pm, Thursday, 15'th Feb 2024
Nvidia (NVDA) has disclosed investments made in several emerging AI companies, sparking rallies across these stocks. Among the names benefiting include Soundhound (SOUN), Arm (ARM), and Nanox (NNOX).
Shares of Smaller AI Firms Rise After Nvidia Discloses Investments
03:19pm, Thursday, 15'th Feb 2024
Shares of smaller artificial intelligence (AI) firms reportedly experienced a rally Thursday (Feb. 15) after Nvidia, the world's leading AI chipmaker, disclosed its stake in them as of Dec. 31. This
